Charcot Fund: fundamental research
Laureates 2019
In vivo induction of tolerogenic Dendritic Cells via AcTaferon targeting
Prof. Anje Cauwels
UGent / VIB
€50,000
2 ans
The development of a human iPSC-derived in vitro demyelination model for studying the effect of IL13-induced M2-activated macrophages and microglia
Dr. Debbie Leblon and Prof. Peter Ponsaerts
UAntwerpen
€43,000
2 ans
Age-associated B cells as therapeutic targets in MS
Dr. Judith Fraussen and Prof. Veerle Somers
BIOMED - UHasselt
€45,000
2 ans
Boosting lesion repair in multiple sclerosis by preventing lipid overload in phagocytes
Prof. Jerome Hendriks, Prof. Johan Swinnen and Dr. Jeroen Bogie
BIOMED- UHasselt
€53,000
2 ans
Characterization of regulatory B-cell subsets emerging in multiple sclerosis treatment
Prof. An Goris and Prof. Patrick Matthys
KU Leuven
€40,000
2 ans
Exploring the effect of CD27/CD70 costimulation on Th17 vs. Treg cells during autoimmunity
Prof. Dr. Muriel Moser and Dr. Isabel Vogel
ULB
€45,530
Characterization of interleukin-33 (IL-33) as a potential therapeutic target in multiple sclerosis
Dr. Inna Afonina and Prof. Rudi Beyaert
VIB-UGent Center for Inflammation Research
€47,424
2 ans
Therapeutic exploration of novel inhibitors of biological rust in multiple sclerosis
Prof. Tom Vanden Berghe and Prof. Peter Vandenabeele
UGent
€54,550
2 ans
Remyelination stimulation by activin A delivery via MSC-derived extracellular vesicles.
Prof. Anne des Rieux
UCLouvain
€40,000
2 ans
Autologous hematopoietic stem cell transplantation (AHSCT) in MS: a role for B cells?
Prof. Guy Laureys, Prof. Veerle Somers and Dr. Judith Fraussen
UZ Gent and UHasselt -BIOMED
€42,000
2 ans
The epigenetic signature of myelin genes as an innovative biomarker for progressive multiple sclerosis
Dr. Tim Vanmierlo, Prof. Daniel van den Hove and Mme Assia Tiane
UHasselt
€40,000
2 ans
Stay informed
Receive all the information related to research and news from the Belgian Charcot Foundation directly in your inbox.
By clicking on “I register”, you agree to our Privacy policy
